Daly City, CA, United States of America

Xinping Han

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Rapt Therapeutics, Inc.. Active years: 2020-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xinping Han. Retrieved from https://idiyas.com/inventor/xinping-han

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 12.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Daly City, CA (US) (2020 - 2021)
  • Berkeley, CA (US) (2021)

Company Filing History:


Years Active: 2020-2021

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Xinping Han

Introduction

Xinping Han is a notable inventor based in Daly City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of compounds that modulate specific biological activities. With a total of 3 patents to his name, Han's work is recognized for its potential therapeutic applications.

Latest Patents

Han's latest patents include innovative compounds and methods that have garnered attention in the scientific community. One of his notable patents is for "Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof." This patent discloses compounds and methods for modulating USP7 activity, which is crucial for various cellular processes. Another significant patent is for "Pyrazolo-pyrimidin-amino-cycloalkyl compounds and their therapeutic uses." This patent outlines the development of pyrazolo-pyrimidin-amino-cycloalkyl compounds, their analogs, and pharmaceutical compositions, highlighting their therapeutic potential.

Career Highlights

Xinping Han is currently associated with Rapt Therapeutics, Inc., where he continues to innovate and contribute to the field of drug development. His work focuses on creating novel therapeutic agents that can address unmet medical needs. His expertise in the modulation of biological pathways has positioned him as a valuable asset in the biotechnology sector.

Collaborations

Han collaborates with esteemed colleagues, including Dennis X Hu and Paul Robert Leger. These collaborations enhance the research and development efforts at Rapt Therapeutics, Inc., fostering an environment of innovation and discovery.

Conclusion

In summary, Xinping Han is a distinguished inventor whose work in biotechnology has led to the development of important therapeutic compounds. His contributions, reflected in his patents, demonstrate his commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…